Please login to the form below

Not currently logged in
Email:
Password:

Voyager Therapeutics

This page shows the latest Voyager Therapeutics news and features for those working in and with pharma, biotech and healthcare.

Genzyme cuts staff and signs $845m gene therapy pact

Genzyme cuts staff and signs $845m gene therapy pact

Genzyme cuts staff and signs $845m gene therapy pact. Alliance with Voyager Therapeutics revealed on the same day as job losses. ... Sanofi's Genzyme unit has made a major play in the gene therapy sector with a $845m alliance with Voyager Therapeutics.

Latest news

More from news
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest Intelligence

  • Medius Deal Watch table for February 2015 Medius Deal Watch table for February 2015

    Voyager Therapeutics/ Sanofi (Genzyme). Gene therapy - Parkinson's disease, Friedreich's ataxia and Huntington's disease. ... Collaboration - discover, develop, commercialise. 450. Heptares Therapeutics/ Sosei Group . Novel G protein-coupled receptor

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest appointments

More from appointments
Approximately 2 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
M3 (EU)

M3 was founded in 2000 with the goal of changing the world of medicine through making full use of the...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics